HDC, SPM enter into development and licensing agreements with Quest Diagnostics

Health Discovery Corporation (OTCBB: HDVY) (HDC) and Smart Personalized Medicine, LLC (SPM) announced today that they have entered into development and related licensing agreements with Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic testing, information and services. Under the agreements, Quest Diagnostics will develop new laboratory tests for aiding in the selection of breast cancer therapies.

Under the terms of the agreements, HDC and SPM will receive upfront licensing payments, development fees and royalties on a per test basis from Quest Diagnostics.

In February 2009, Health Discovery Corporation announced that it had licensed rights to develop a new urine-based test for clinically significant prostate cancer to Quest Diagnostics.

Source:

Health Discovery Corporation

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Quest Diagnostics. (2019, June 19). HDC, SPM enter into development and licensing agreements with Quest Diagnostics. News-Medical. Retrieved on May 24, 2024 from https://www.news-medical.net/news/20100317/HDC-SPM-enter-into-development-and-licensing-agreements-with-Quest-Diagnostics.aspx.

  • MLA

    Quest Diagnostics. "HDC, SPM enter into development and licensing agreements with Quest Diagnostics". News-Medical. 24 May 2024. <https://www.news-medical.net/news/20100317/HDC-SPM-enter-into-development-and-licensing-agreements-with-Quest-Diagnostics.aspx>.

  • Chicago

    Quest Diagnostics. "HDC, SPM enter into development and licensing agreements with Quest Diagnostics". News-Medical. https://www.news-medical.net/news/20100317/HDC-SPM-enter-into-development-and-licensing-agreements-with-Quest-Diagnostics.aspx. (accessed May 24, 2024).

  • Harvard

    Quest Diagnostics. 2019. HDC, SPM enter into development and licensing agreements with Quest Diagnostics. News-Medical, viewed 24 May 2024, https://www.news-medical.net/news/20100317/HDC-SPM-enter-into-development-and-licensing-agreements-with-Quest-Diagnostics.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
IBM, Quest Diagnostics launch new genomic tumor sequencing service to help advance precision medicine